Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03JSO
|
|||
| Former ID |
DIB001119
|
|||
| Drug Name |
ASP-2535
|
|||
| Indication | Schizophrenia [ICD-11: 6A20] | Discontinued in Phase 1 | [1] | |
| Company |
Astellas Pharma Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H18N6O
|
|||
| Canonical SMILES |
CC(C)C1=NN=C(N1C2=CC=CC3=NON=C32)C4=CN=C(C=C4)C5=CC=CC=C5
|
|||
| InChI |
1S/C22H18N6O/c1-14(2)21-24-25-22(28(21)19-10-6-9-18-20(19)27-29-26-18)16-11-12-17(23-13-16)15-7-4-3-5-8-15/h3-14H,1-2H3
|
|||
| InChIKey |
FQGLDGKVKDPVLO-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 374886-51-8
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028968) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.